{"id":17443,"date":"2018-03-12T11:50:36","date_gmt":"2018-03-12T10:50:36","guid":{"rendered":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/"},"modified":"2018-03-13T09:53:33","modified_gmt":"2018-03-13T08:53:33","slug":"no-definitivo-las-ates","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/","title":{"rendered":"&#8220;No&#8221; definitivo a las &#8220;ATEs&#8221;"},"content":{"rendered":"<p><strong>Antecedentes<\/strong><\/p>\n<p>En julio de 2013 el Servicio Andaluz de Salud abri\u00f3 la licitaci\u00f3n de un llamado \u201cAcuerdo Marco de homologaci\u00f3n para la selecci\u00f3n de principios activos para determinadas indicaciones\u201d. El objeto era seleccionar, para cada lote licitado, un proveedor que suministrar\u00eda uno de los medicamentos que se pod\u00edan ofertar en cada lote. Los lotes se configuraban por indicaciones terap\u00e9uticas. As\u00ed, por ejemplo, en el lote 18 se pod\u00edan ofertar Anti-TNFs y hasta 5 medicamentos biol\u00f3gicos para el tratamiento de la artritis reumatoide; en el 19 se pod\u00edan ofertar diversos biol\u00f3gicos contra la espondilitis anquilosante, y en el lote 20 se pod\u00edan ofertar dos principios activos distintos para el tratamiento en segunda l\u00ednea de la esclerosis m\u00faltiple. El objetivo era seleccionar un \u00fanico medicamento que se incorporase a las gu\u00edas de los hospitales andaluces para su dispensaci\u00f3n a pacientes. El SAS, a sabiendas de los problemas que se avecinaban, inclu\u00eda en los pliegos la idea de que un medicamento no seleccionado podr\u00eda ser prescrito cuando existieran \u201cfactores cl\u00ednicos\u201d relevantes.<\/p>\n<p>Otros \u00f3rganos de contrataci\u00f3n emprendieron iniciativas similares y todo ello aviv\u00f3 el debate sobre la selecci\u00f3n de medicamentos en los hospitales, la libertad de prescripci\u00f3n, y la sustituci\u00f3n de ciertos productos, debate que en buena medida sigue abierto todav\u00eda hoy.<\/p>\n<p><strong>C\u00f3mo deben configurarse los lotes<\/strong><\/p>\n<p>En 2013, al preparar varios recursos contra los pliegos andaluces, nos apoyamos en una resoluci\u00f3n del Tribunal Administrativo Central de Recursos Contractuales, de 27 de marzo de 2013, contra unos pliegos del INGESA. En ese caso, se decidi\u00f3 que la l\u00f3gica de la regulaci\u00f3n sanitaria impone que lo correcto es dise\u00f1ar las licitaciones por principio activo y no por indicaciones, porque el perfil terap\u00e9utico de cada producto est\u00e1 sujeto a interpretaciones, y porque el hecho de que dos productos puedan estar indicados para la misma patolog\u00eda no supone que puedan ser intercambiables. Los recursos interpuestos en Andaluc\u00eda no prosperaron ni en v\u00eda administrativa ni en la primera instancia judicial. En 2016, el Tribunal Supremo dict\u00f3 una sentencia en contra de las ATEs previstas en un concurso convocado por Instituciones Penitenciarias. El SAS, por su parte, sigui\u00f3 defendiendo su Acuerdo Marco a ultranza.<\/p>\n<p>En esta sentencia, el Tribunal Supremo ha puesto fin al debate en torno a las ATEs. El Tribunal concluye sin fisuras que dos productos distintos no pueden integrarse en un mismo lote, ya que ello incumple la exigencia de que los lotes formen una unidad funcional. Se ha validado por tanto el criterio que en su d\u00eda fij\u00f3 el Tribunal Administrativo Central de Recursos Contractuales.<\/p>\n<p>Despu\u00e9s de la primera sentencia de 2016 en el caso de Instituciones Penitenciarias, esta segunda sentencia ya genera jurisprudencia y deber\u00eda ser suficiente para enterrar de una vez por todas la idea de las ATEs y de que pueden convocarse concursos configurando los lotes por indicaciones terap\u00e9uticas incluyendo en dichos lotes productos que no sean intercambiables.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Antecedentes En julio de 2013 el Servicio Andaluz de Salud abri\u00f3 la licitaci\u00f3n de un llamado \u201cAcuerdo Marco de homologaci\u00f3n para la selecci\u00f3n de principios activos para determinadas indicaciones\u201d. El objeto era seleccionar, para cada lote licitado, un proveedor que suministrar\u00eda uno de los medicamentos que se pod\u00edan ofertar en cada lote. Los lotes se&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/\" class=\"excerpt-read-more\">M\u00e9s informaci\u00f3<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[272,318,286,311],"tags":[],"coauthors":[],"class_list":["post-17443","post","type-post","status-publish","format-standard","hentry","category-capsulas-ca","category-contractacio-publica","category-dret-farmaceutic-i-life-sciences","category-regulatory-dret-farmaceutic-i-life-sciences"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>&quot;No&quot; definitivo a las &quot;ATEs&quot; - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"&quot;No&quot; definitivo a las &quot;ATEs&quot; - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"Antecedentes En julio de 2013 el Servicio Andaluz de Salud abri\u00f3 la licitaci\u00f3n de un llamado \u201cAcuerdo Marco de homologaci\u00f3n para la selecci\u00f3n de principios activos para determinadas indicaciones\u201d. El objeto era seleccionar, para cada lote licitado, un proveedor que suministrar\u00eda uno de los medicamentos que se pod\u00edan ofertar en cada lote. Los lotes se... M\u00e9s informaci\u00f3\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-12T10:50:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-13T08:53:33+00:00\" \/>\n<meta name=\"author\" content=\"Jordi Faus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jordi Faus\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n\t<meta name=\"twitter:label3\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data3\" content=\"Jordi Faus\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/\"},\"author\":{\"name\":\"Jordi Faus\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\"},\"headline\":\"&#8220;No&#8221; definitivo a las &#8220;ATEs&#8221;\",\"datePublished\":\"2018-03-12T10:50:36+00:00\",\"dateModified\":\"2018-03-13T08:53:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/\"},\"wordCount\":507,\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"articleSection\":[\"Capsulas\",\"Contractaci\u00f3 P\u00fablica\",\"Dret Farmac\u00e8utic i \u201cLife Sciences\u201d\",\"Regulatory\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/\",\"url\":\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/\",\"name\":\"\\\"No\\\" definitivo a las \\\"ATEs\\\" - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\"},\"datePublished\":\"2018-03-12T10:50:36+00:00\",\"dateModified\":\"2018-03-13T08:53:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/faus-moliner.com\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"&#8220;No&#8221; definitivo a las &#8220;ATEs&#8221;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/faus-moliner.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/2372042\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\",\"name\":\"Jordi Faus\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"caption\":\"Jordi Faus\"},\"description\":\"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.\",\"sameAs\":[\"https:\/\/faus-moliner.com\/\"],\"url\":\"https:\/\/faus-moliner.com\/ca\/author\/jordi-faus\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\"No\" definitivo a las \"ATEs\" - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/","og_locale":"ca_ES","og_type":"article","og_title":"\"No\" definitivo a las \"ATEs\" - Faus Moliner","og_description":"Antecedentes En julio de 2013 el Servicio Andaluz de Salud abri\u00f3 la licitaci\u00f3n de un llamado \u201cAcuerdo Marco de homologaci\u00f3n para la selecci\u00f3n de principios activos para determinadas indicaciones\u201d. El objeto era seleccionar, para cada lote licitado, un proveedor que suministrar\u00eda uno de los medicamentos que se pod\u00edan ofertar en cada lote. Los lotes se... M\u00e9s informaci\u00f3","og_url":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/","og_site_name":"Faus Moliner","article_published_time":"2018-03-12T10:50:36+00:00","article_modified_time":"2018-03-13T08:53:33+00:00","author":"Jordi Faus","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Jordi Faus","Temps estimat de lectura":"3 minuts","Written by":"Jordi Faus"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/"},"author":{"name":"Jordi Faus","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260"},"headline":"&#8220;No&#8221; definitivo a las &#8220;ATEs&#8221;","datePublished":"2018-03-12T10:50:36+00:00","dateModified":"2018-03-13T08:53:33+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/"},"wordCount":507,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"articleSection":["Capsulas","Contractaci\u00f3 P\u00fablica","Dret Farmac\u00e8utic i \u201cLife Sciences\u201d","Regulatory"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/","url":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/","name":"\"No\" definitivo a las \"ATEs\" - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"datePublished":"2018-03-12T10:50:36+00:00","dateModified":"2018-03-13T08:53:33+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/ca\/no-definitivo-las-ates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/ca\/"},{"@type":"ListItem","position":2,"name":"&#8220;No&#8221; definitivo a las &#8220;ATEs&#8221;"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260","name":"Jordi Faus","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5","url":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","caption":"Jordi Faus"},"description":"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.","sameAs":["https:\/\/faus-moliner.com\/"],"url":"https:\/\/faus-moliner.com\/ca\/author\/jordi-faus\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/posts\/17443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/comments?post=17443"}],"version-history":[{"count":0,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/posts\/17443\/revisions"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/media?parent=17443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/categories?post=17443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/tags?post=17443"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/coauthors?post=17443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}